Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease

Key Points

• Lipoprotein(a) levels vary significantly across different regions globally, impacting coronary heart disease risk.
• In populations with higher levels of lipoprotein(a), there is a corresponding increase in coronary heart disease occurrence.
• Observational analysis of patient data from multiple countries illustrates the global nature of these variations.
• These findings highlight the need for location-specific strategies in managing coronary heart disease related to lipoprotein(a) levels.